Results 31 to 40 of about 8,934 (195)

Table_3_Identification of mRNA Prognostic Markers for TGCT by Integration of Co-Expression and CeRNA Network.xlsx

open access: yes, 2021
Testicular germ cell tumor (TGCT) is the most common malignant tumor in young men and is associated with poor prognosis. We assessed the RNA expression profiles of 13 TGCT tissues and 4 adjacent normal tissues by transcriptome sequencing to identify ...
Zhizhong Liu (157561)   +8 more
core   +1 more source

Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics

open access: yesFrontiers in Endocrinology, 2013
Introduction: Risk of testicular germ cell tumors (TGCT) is consistently associated with a history of cryptorchidism (CO) in epidemiologic studies. Factors modifying the association may provide insights regarding etiology of TGCT and suggest a basis for ...
Kimberly eBanks   +18 more
doaj   +1 more source

Lower abdominal and pelvic radiation and testicular germ cell tumor risk.

open access: yesPLoS ONE, 2020
BackgroundTesticular germ cell tumor (TGCT) incidence has increased in recent decades along with the use and dose of diagnostic radiation. Here we examine the association between reported exposure to diagnostic radiation and TGCT risk.MethodsWe conducted
Kevin T Nead   +9 more
doaj   +1 more source

Identification of testicular cancer immune infiltrates and novel immune cell subtypes

open access: yesFEBS Open Bio, 2023
Testicular germ cell tumors (TGCT) are the most common type of testicular cancer, comprising 90–95% of cases and representing the most prevalent solid malignancy in young adult men.
Zhiguo Zhu   +5 more
doaj   +1 more source

Dataset of testicular germ cell tumors (TGCT) risk associated with serum polychlorinated biphenyl (PCB) by age at diagnosis and histologic types

open access: yesData in Brief, 2021
In a population-based case control study of testicular germ cell tumors (TGCT), we reported a strong positive association between serum levels of Wolff's Group 1 (potentially estrogenic) polychlorinated biphenyl (PCBs) and risk of TGCT, and the observed ...
Zhiyuan Cheng   +14 more
doaj   +1 more source

Table_1_Identification of mRNA Prognostic Markers for TGCT by Integration of Co-Expression and CeRNA Network.xlsx

open access: yes, 2021
Testicular germ cell tumor (TGCT) is the most common malignant tumor in young men and is associated with poor prognosis. We assessed the RNA expression profiles of 13 TGCT tissues and 4 adjacent normal tissues by transcriptome sequencing to identify ...
Zhizhong Liu (157561)   +8 more
core   +1 more source

Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy

open access: yesBMC Cancer, 2018
Background Although tenosynovial giant cell tumor (TGCT) is classified as a benign tumor, it may undergo malignant transformation and metastasize in extremely rare occasions. High aberrant expression of CSF1 has been implicated in the development of TGCT
Robert Nakayama   +7 more
doaj   +1 more source

Long non-coding RNA TTTY14 promotes cell proliferation and functions as a prognostic biomarker in testicular germ cell tumor

open access: yesHeliyon, 2023
Testicular germ cell tumors (TGCTs) commonly occur in males between the ages of 15 and 34, accounting for 98% of testicular malignancies. Long non-coding RNAs (LncRNAs) have been reported to play important roles in TGCT proliferation, invasion, and ...
Jian Cao   +5 more
doaj   +1 more source

Long-term follow-up of nilotinib in patients with advanced tenosynovial giant cell tumours long-term follow-up of nilotinib in TGCT [PDF]

open access: yes, 2022
Background: Diffuse-type tenosynovial giant cell tumour (D-TGCT) is a nonmalignant but locally aggressive tumour driven by overexpression of colony-stimulating factor-1 (CSF1).
Blay, J.Y.   +33 more
core   +1 more source

Secondary leukaemia after testicular germ cell tumour treatment: a systematic review and meta-analysis. [PDF]

open access: yesBJU Int
Background Testicular germ cell tumours (TGCTs) are the most common malignancy in men aged 15–35 years. Management options for men with TGCTs include surgery, radiation and/or chemotherapy, depending on stage. Given TGCTs’ excellent survival, most patients live long enough to experience delayed treatment toxicities, warranting careful consideration of ...
Mousa A   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy